NCT05651867Completed
EPIONE Guided Lung Evaluation
Prospective Clinical Investigation on the Evaluation of Performance and Safety of the EPIONE Assisted CT-guided Percutaneous Procedures in the Lungs
Source: ClinicalTrials.gov · Last updated 15 Jul 2025
Brief summary (registry, in English)
Interventional clinical study to obtain performance and safety data of the EPIONE® device when used for percutaneous procedures in the lung.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 25 (actual)
- First submitted
- 28 Nov 2022
- Start date
- 28 Nov 2022
- Primary completion date
- 25 Aug 2023
- Lead sponsor
- Quantum Surgical
- Diseases
- Lung cancer
- NCT number
- NCT05651867
What you commit to
- Study type: Interventional
- Participants enrolled: 25
- From 28 Nov 2022 to the primary completion date, 25 Aug 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Patient unable to undergo general anesthesia,
- Pregnant or nursing female, confirmed before the intervention
- Patient already participating in another clinical study
Who the study is looking for
- Patient ≥18 years old,
- Patient for whom a percutaneous CT-guided intervention in lung has been prescribed and agreed by a multidisciplinary team of radiologists, surgeons and clinicians,
- Patient with a signed informed consent form.
- Patient covered by a social security system.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Gustave Roussy Institut Coordinator of this site? Confirm its status | Villejuif | France | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.